Dapsone and sulfapyridine.
Uetrecht
J
J
Faculty of Pharmacy, University of Toronto, School of Medicine, Ontario, Canada.
D002465:Cell Movement; D003622:Dapsone / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D007918:Leprosy / Q000188:drug therapy; D008708:Methemoglobinemia / Q000139:chemically induced; D009504:Neutrophils / Q000378:metabolism; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy; D013424:Sulfanilamides / Q000008:administration & dosage*; D013427:Sulfapyridine / Q000008:administration & dosage*; D014657:Vasculitis / Q000188:drug therapy
D013424:Sulfanilamides; D003622:Dapsone; D013427:Sulfapyridine